首页> 外文期刊>Bone marrow transplantation >Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation.
【24h】

Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation.

机译:在最初的造血干细胞移植咨询中,患者对疾病状况和治疗计划的了解。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients referred for hematopoietic stem cell transplantation (HSCT) often have knowledge deficits about their disease and overestimate their prognosis making it difficult initially to discuss potentially life-threatening transplant options. To determine patients' understanding of their disease and the adequacy of a 3-h consultation at our center, we developed a survey that measured perceived knowledge deficits of disease, prognosis, and emotional status before and after their initial consultation. Ninety nine consecutive eligible patients completed the survey. Although 76.7% claimed adequate information about their disease pre-HCST visit, 51.5 and 41.4% respectively lacked knowledge about their 1-year prognosis with and without any therapy. After the visit, 66.7% of the patients had obtained enough information to make an informed decision regarding HSCT versus 23.2% pre-visit, and a significant reduction in the need for further information was reported by 53.5% of patients (P<0.001). Patients were notoverwhelmed or confused by the visit and there was a small but significant decrease in negative affect. Measures to increase patients understanding of their disease and its prognosis pre-HSCT consultation visit are warranted; however, a 3-h consultation visit provides the majority of patients with sufficient information to make an informed decision about the risk/benefit ratio of HSCT.
机译:接受造血干细胞移植(HSCT)咨询的患者通常对疾病了解不足,并且高估了其预后,因此一开始就很难讨论可能威胁生命的移植方案。为了确定患者对疾病的了解以及在我们中心进行3小时咨询的充分性,我们开展了一项调查,该调查测量了他们在初诊之前和之后对疾病,预后和情绪状况的认知知识缺陷。连续九十九名合格患者完成了调查。尽管76.7%的患者声称在HCST访视前有足够的有关其疾病的信息,但分别有51.5%和41.4%的患者不了解接受或不接受任何疗法的1年预后。访视后,有66.7%的患者获得了足够的信息以做出有关HSCT的知情决定,而访前为23.2%,据报道53.5%的患者对进一步信息的需求显着减少(P <0.001)。拜访并没有使患者不知所措或感到困惑,负面影响也有很小但明显的减少。有必要采取措施增加患者对其疾病及其在HSCT咨询前就诊的预后的了解;然而,为期3小时的咨询拜访为大多数患者提供了足够的信息,以便他们就HSCT的风险/收益比做出明智的决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号